Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FUJIFILM enters definitive agreement to acquire Merck

FUJIFILM Corporation and Merck, known as MSD outside the United States and Canada, today announced they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceutical industry and wholly owned by Merck.

28 Feb 2011

Samsung enters strategic partnership with Quintiles to support biopharmaceuticals market

Samsung Electronics Co., Ltd., the world's largest electronics company, and its affiliated companies have entered into a strategic partnership with Quintiles, the world's leading pharmaceutical services company, to support Samsung's entry into the biopharmaceuticals market, Quintiles announced today.

27 Feb 2011

Humana CEO hails the importance of the health care consumer

But on Capitol Hill, Rep. Pete Stark, D-Calif., released a fact sheet detailing the profits earned by the nation's five largest insurers — including Humana — and touted health law provisions that would increase transparency from the insurance industry.

25 Feb 2011

IPG Photonics fourth quarter revenues increase 86% year-over-year to $101 million

IPG Photonics Corporation today reported financial results for the fourth quarter of fiscal 2010 ended December 31, 2010.

25 Feb 2011

General Nutrition Centers fourth quarter net income increases 56.3% to $19.8 million

General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the year and quarter ended December 31, 2010.

25 Feb 2011

Savient launches KRYSTEXXA in the U.S.

Savient Pharmaceuticals, Inc. announced the official full U.S. commercial launch of KRYSTEXXA™ (pegloticase), which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic gout in adult patients refractory to conventional therapy. KRYSTEXXA is now the first and only therapy available to address this unmet medical need.

25 Feb 2011

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).

25 Feb 2011

Western Digital establishes new HDD research and development center in Singapore

Western Digital announced today that it has established a research and development center in Singapore, where the company will leverage the local talent pool and expertise of research organizations, such as Singapore's A*STAR Data Storage Institute, and universities in the development of advanced hard drive technologies.

25 Feb 2011

Bruker to acquire Michrom Bioresources

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.

24 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Survey: 67% of pharma and biotech companies outsource more than half of all clinical trials

Driving clinical development and speeding time to market through effective relationship management will be two of the key themes discussed at Pharma IQ's 2nd Annual Global Clinical Outsourcing Forum this May.

23 Feb 2011

MWV announces availability of preservative pharmaceutical spray pumps for sampling

MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.

23 Feb 2011

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

22 Feb 2011

CARBOGEN AMCIS installs new stability chambers at Switzerland facility

Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonisation (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.

21 Feb 2011

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.

21 Feb 2011

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Australian health care company Prima BioMed Ltd announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.

19 Feb 2011

Novavax announces final safety, immunogenicity results from H1N1 VLP vaccine at WHO meeting

Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.

19 Feb 2011

China-Biotics applies 5 new patents for probiotics supplement, preparation

China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced it has applied for 5 new patents through its wholly owned subsidiary Growing Bioengineering to the State Bureau of Intellectual Property.

18 Feb 2011

San Francisco area patient files DePuy hip replacement recall lawsuit

Wendy R. Fleishman, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Alec MacPhail, of Danville, California, has filed a personal injury lawsuit against DePuy Orthopedics, Inc., and its parent company, Johnson & Johnson, Inc., for manufacturing an allegedly defective prosthetic hip implant device sold under the brand name DePuy ASR XL Acetabular System.

18 Feb 2011

Inspire announces strategic corporate restructuring on its eye care business

Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.

17 Feb 2011

Manufacturing News and Research

Further Reading

FUJIFILM enters definitive agreement to acquire Merck

Samsung enters strategic partnership with Quintiles to support biopharmaceuticals market

Humana CEO hails the importance of the health care consumer

IPG Photonics fourth quarter revenues increase 86% year-over-year to $101 million

General Nutrition Centers fourth quarter net income increases 56.3% to $19.8 million

Savient launches KRYSTEXXA in the U.S.

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Western Digital establishes new HDD research and development center in Singapore

Bruker to acquire Michrom Bioresources

Australia’s top scientist takes on top job

Survey: 67% of pharma and biotech companies outsource more than half of all clinical trials

MWV announces availability of preservative pharmaceutical spray pumps for sampling

FDA refuses Delcath's chemosaturation delivery system NDA filing

CARBOGEN AMCIS installs new stability chambers at Switzerland facility

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Novavax announces final safety, immunogenicity results from H1N1 VLP vaccine at WHO meeting

China-Biotics applies 5 new patents for probiotics supplement, preparation

San Francisco area patient files DePuy hip replacement recall lawsuit

Inspire announces strategic corporate restructuring on its eye care business

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News